Industry News
Pharmaceutical Industry News
Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts
Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts kdunleavy Wed, 06/01/2022 - 06:51
Pfizer topples oncology giant Roche in cancer patient groups’ reputation list
Pfizer topples oncology giant Roche in cancer patient groups' reputation list badams Wed, 06/01/2022 - 04:34
The Doctor Prescribed an Obesity Drug. Her Insurer Called It ‘Vanity.’
Many insurance companies refuse to cover new weight loss drugs that their doctors deem medically necessary.
Former AstraZeneca exec charged with insider trading in Daiichi Sankyo’s licensing deal
Former AstraZeneca exec charged with insider trading in Daiichi Sankyo's licensing deal kdunleavy Tue, 05/31/2022 - 16:48
Sanofi and Regeneron’s pipeline-in-a drug Dupixent nabs priority review for yet another use
Sanofi and Regeneron's pipeline-in-a drug Dupixent nabs priority review for yet another use zbecker Tue, 05/31/2022 - 15:35
ASCO preview: How Gilead, Pfizer, AstraZeneca-Daiichi breast cancer data may—or may not—change treatment practice
ASCO preview: How Gilead, Pfizer, AstraZeneca-Daiichi breast cancer data may—or may not—change treatment practice aliu Tue, 05/31/2022 - 12:03
After $500M IPO, HK inno.N enters exosome drug delivery via Ilias pact
After $500M IPO, HK inno.N enters exosome drug delivery via Ilias pact ntaylor Tue, 05/31/2022 - 10:34
Bavarian Nordic expects revenue boost after inking deals to supply monkeypox vaccine to more countries
Bavarian Nordic expects revenue boost after inking deals to supply monkeypox vaccine to more countries zbecker Tue, 05/31/2022 - 10:34
Roche’s Evrysdi ramps up SMA rivalry with Novartis and Biogen thanks to FDA nod in newborns
Roche's Evrysdi ramps up SMA rivalry with Novartis and Biogen thanks to FDA nod in newborns kdunleavy Tue, 05/31/2022 - 10:31
SciSparc unlocks nasal cannabinoid delivery via Polyrizon pact
SciSparc unlocks nasal cannabinoid delivery via Polyrizon pact ntaylor Tue, 05/31/2022 - 10:03
Bristol Myers’ Opdivo fights Keytruda again with dual FDA nods in esophageal cancer
Bristol Myers' Opdivo fights Keytruda again with dual FDA nods in esophageal cancer aliu Tue, 05/31/2022 - 09:54
MIT, Brigham push oral, oil-based delivery gel toward clinic to expand pediatric toolkit
MIT, Brigham push oral, oil-based delivery gel toward clinic to expand pediatric toolkit ntaylor Tue, 05/31/2022 - 08:48
Jubilant snags $146.6M US contract to double injectables production
Jubilant snags $146.6M US contract to double injectables production jkeenan Tue, 05/31/2022 - 08:29
Novartis’ Kymriah bags FDA nod to face off against Gilead’s Yescarta in follicular lymphoma
Novartis' Kymriah bags FDA nod to face off against Gilead's Yescarta in follicular lymphoma aliu Tue, 05/31/2022 - 05:34
A Balm for Psyches Scarred by War
MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.
Moderna CEO pledges to donate most of his $4B fortune: Bloomberg
Moderna CEO pledges to donate most of his $4B fortune: Bloomberg esagonowsky Fri, 05/27/2022 - 10:14
Fraudster in Gilead’s counterfeiting case gets prison sentence in a separate suit with an unnamed pharma for $7.2M in bogus reimbursement claims
Fraudster in Gilead's counterfeiting case gets prison sentence in a separate suit with an unnamed pharma for $7.2M in bogus reimbursement claims fkansteiner Fri, 05/27/2022 - 10:14
Fierce Pharma Asia—J&J, Legend’s new CAR-T data; Junshi’s antiviral tops Pfizer’s Paxlovid; Vir, WuXi end COVID pact
Fierce Pharma Asia—J&J, Legend's new CAR-T data; Junshi's antiviral tops Pfizer's Paxlovid; Vir, WuXi end COVID pact aliu Fri, 05/27/2022 - 10:10
GSK’s ViiV to work with Medicines Patent Pool, generic manufacturers to bolster access to long-acting HIV prevention med Apretude
GSK's ViiV to work with Medicines Patent Pool, generic manufacturers to bolster access to long-acting HIV prevention med Apretude fkansteiner Fri, 05/27/2022 - 08:32
Pfizer and Moderna rapidly falling out of favor as Americans’ favorite brands: report
Pfizer and Moderna rapidly falling out of favor as Americans' favorite brands: report badams Fri, 05/27/2022 - 07:15